International Patent: METHODS AND SYSTEMS FOR PREDICTION OF IMMUNE CHECKPOINT INHIBITION THERAPEUTIC RESPONSE AND TOXICITY FROM AN IMMUNE SIGNATURE

GENEVA, Aug. 31 -- MELIO HEALTHCARE LIMITED filed a patent application (US2026/016096) for “METHODS AND SYSTEMS FOR PREDICTION OF IMMUNE CHECKPOINT INHIBITION THERAPEUTIC RESPONSE AND TOXICITY FROM AN IMMUNE SIGNATURE”. With publication no. WO/2026/178401, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 15/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....